(Paris:DSY.PA),(Paris:SAN),(NASDAQ:SNY), NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) — Medidata, a Dassault Systemes brand and leading provider of clinical trial solutions to the life sciences industry, and Sanofi today announced an expansion of their partnership to bolster clinical research. This new agreement will take advantage of the Medidata Patient, Data, and Study Experiences, building on […]

(Paris:NEX), 9M 2025 financial informationNomination of Julien Hueber as CEO of Nexans in OctoberPowering the future with growth and strategic leadership transition9M 2025: Robust Electrification businesses, up +9.4% organically driving Group organic growth to +5.8%Acquisition of Electro Cables, reinforcing Nexans in PWR-Connect in Canada2025 guidance reiterated High 9M 2025 Group organic growth at +5.8%, including

(Helsinki:NOKIA),(Irish:IRSH),(LSE:0HAF),(Paris:NOKIA), Nokia CorporationInterim Report23 October 2025 at 08:00 EEST Nokia Corporation Interim Report for Q3 2025 Strong net sales growth, well on track to achieve full year outlook Q3 comparable net sales grew 9% y-o-y on a constant currency and portfolio basis (12% reported) with all business groups contributing and particularly strong growth in Optical

(Paris:SW), Issy-les-Moulineaux, October 23, 2025 Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY) Fiscal 2025 results: Organic revenue growth of +3.3%, or +3.7% underlying1 Underlying operating profit margin at 4.7%, up +10bps at constant currencies Underlying group net profit at 785 million euros, up +3.7% at constant currencies Solid free cashflow; net debt/EBITDA ratio of 1.8x Proposed

(Paris:STMPA),(NYSE:STM), PR No: C3364C STMicroelectronics Reports 2025 Third Quarter Financial Results Q3 net revenues $3.19 billion; gross margin 33.2%; operating income of $180 million, including $37 million related to impairment, restructuring charges and other related phase-out costs; net income of $237 million Business outlook at mid-point: Q4 net revenues of $3.28 billion and gross margin

(Brussels:ARGX),(NASDAQ:ARGX), October 23, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, October 30, 2025 at 1:30 PM CET (8:30 AM ET) to discuss

Nexans – 9M 2025, Powering the future with growth and strategic leadership transition GlobeNewswire October 23, 2025 9M 2025 financial informationNomination of Julien Hueber as CEO of Nexans in OctoberPowering the future with growth and strategic leadership transition9M 2025: Robust Electrification businesses, up +9.4% organically driving Group organic growth to +5.8%Acquisition of Electro Cables, reinforcing

Nokia Corporation Interim Report for Q3 2025 GlobeNewswire October 23, 2025 Nokia CorporationInterim Report23 October 2025 at 08:00 EEST Nokia Corporation Interim Report for Q3 2025 Strong net sales growth, well on track to achieve full year outlook Q3 comparable net sales grew 9% y-o-y on a constant currency and portfolio basis (12% reported) with

Sodexo Fiscal 2025 results in line with revised guidance; Fiscal 2026 as a transition year laying foundation for the future GlobeNewswire October 23, 2025 Issy-les-Moulineaux, October 23, 2025 Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY) Fiscal 2025 results: Organic revenue growth of +3.3%, or +3.7% underlying1 Underlying operating profit margin at 4.7%, up +10bps at constant

argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025 GlobeNewswire October 23, 2025 October 23, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference